CLPT logo

ClearPoint Neuro (CLPT) Shareholders Equity

Annual Shareholders Equity

$21.17 M
-$15.71 M-42.60%

31 December 2023

CLPT Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$29.00 M
-$3.13 M-9.74%

30 September 2024

CLPT Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CLPT Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-42.6%+20.4%
3 y3 years+790.7%-34.3%
5 y5 years+1301.3%+382.7%

CLPT Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-56.6%+790.7%-40.6%+37.0%
5 y5 years-56.6%+1301.3%-40.6%>+9999.0%
alltimeall time-56.6%+196.9%-40.6%+232.8%

ClearPoint Neuro Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$29.00 M(-9.7%)
June 2024
-
$32.13 M(-7.1%)
Mar 2024
-
$34.58 M(+63.3%)
Dec 2023
$21.17 M(-42.6%)
$21.17 M(-12.1%)
Sept 2023
-
$24.09 M(-12.1%)
June 2023
-
$27.41 M(-15.9%)
Mar 2023
-
$32.58 M(-11.7%)
Dec 2022
$36.89 M(-24.4%)
$36.89 M(-7.5%)
Sept 2022
-
$39.88 M(-6.9%)
June 2022
-
$42.82 M(-6.4%)
Mar 2022
-
$45.73 M(-6.3%)
Dec 2021
$48.79 M(+1952.5%)
$48.79 M(+10.6%)
Sept 2021
-
$44.12 M(-8.0%)
June 2021
-
$47.97 M(+9.1%)
Mar 2021
-
$43.98 M(+1750.3%)
Dec 2020
$2.38 M(-48.2%)
$2.38 M(+1494.2%)
Sept 2020
-
$149.10 K(-88.9%)
June 2020
-
$1.34 M(-51.5%)
Mar 2020
-
$2.76 M(-39.8%)
Dec 2019
$4.59 M(+203.5%)
$4.59 M(-23.7%)
Sept 2019
-
$6.01 M(-13.0%)
June 2019
-
$6.91 M(+1460.6%)
Mar 2019
-
$442.60 K(-70.7%)
Dec 2018
$1.51 M
$1.51 M(-39.4%)
Sept 2018
-
$2.49 M(-30.0%)
DateAnnualQuarterly
June 2018
-
$3.56 M(-25.1%)
Mar 2018
-
$4.75 M(-18.5%)
Dec 2017
$5.83 M(-870.9%)
$5.83 M(-19.9%)
Sept 2017
-
$7.28 M(-14.6%)
June 2017
-
$8.53 M(-486.8%)
Mar 2017
-
-$2.20 M(+191.6%)
Dec 2016
-$756.10 K(-61.8%)
-$756.10 K(-231.6%)
Sept 2016
-
$574.60 K(-114.5%)
June 2016
-
-$3.96 M(+9.7%)
Mar 2016
-
-$3.61 M(+82.4%)
Dec 2015
-$1.98 M(+1875.2%)
-$1.98 M(-66.0%)
Sept 2015
-
-$5.82 M(-1.0%)
June 2015
-
-$5.88 M(+62.0%)
Mar 2015
-
-$3.63 M(+3519.2%)
Dec 2014
-$100.30 K(-98.5%)
-$100.30 K(-98.7%)
Sept 2014
-
-$7.93 M(+75.8%)
June 2014
-
-$4.51 M(+43.7%)
Mar 2014
-
-$3.14 M(-54.1%)
Dec 2013
-$6.83 M(-13.1%)
-$6.83 M(+21.8%)
Sept 2013
-
-$5.61 M(+99.1%)
June 2013
-
-$2.82 M(+53.9%)
Mar 2013
-
-$1.83 M(-76.7%)
Dec 2012
-$7.87 M(-64.0%)
-$7.87 M(+36.1%)
Sept 2012
-
-$5.78 M(-46.2%)
June 2012
-
-$10.73 M(-50.9%)
Dec 2011
-$21.84 M
-$21.84 M

FAQ

  • What is ClearPoint Neuro annual stockholders equity?
  • What is the all time high annual shareholders equity for ClearPoint Neuro?
  • What is ClearPoint Neuro annual shareholders equity year-on-year change?
  • What is ClearPoint Neuro quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for ClearPoint Neuro?
  • What is ClearPoint Neuro quarterly shareholders equity year-on-year change?

What is ClearPoint Neuro annual stockholders equity?

The current annual shareholders equity of CLPT is $21.17 M

What is the all time high annual shareholders equity for ClearPoint Neuro?

ClearPoint Neuro all-time high annual stockholders equity is $48.79 M

What is ClearPoint Neuro annual shareholders equity year-on-year change?

Over the past year, CLPT annual stockholders equity has changed by -$15.71 M (-42.60%)

What is ClearPoint Neuro quarterly stockholders equity?

The current quarterly shareholders equity of CLPT is $29.00 M

What is the all time high quarterly shareholders equity for ClearPoint Neuro?

ClearPoint Neuro all-time high quarterly stockholders equity is $48.79 M

What is ClearPoint Neuro quarterly shareholders equity year-on-year change?

Over the past year, CLPT quarterly stockholders equity has changed by +$4.91 M (+20.37%)